Clinical Trial Update: Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy [NA]

View source ↗

Summary

A completed clinical trial evaluating imaging of HER2 expression in breast cancer using a Technetium-99m radiopharmaceutical prior to chemotherapy or targeted t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• [99mTc]Tc-G3-(G3S)3C (Technetium-99m labeled G3-(G3S)3C imaging agent)

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Breast Cancer Female | NA | Status: COMPLETED